MY KOLKATA EDUGRAPH
ADVERTISEMENT
regular-article-logo Saturday, 23 November 2024

Johnson & Johnson seeks India nod for jab trials for children

Pharma major wants to perform study on kids aged between 12 to 17

Reuters New Delhi Published 20.08.21, 02:26 PM
Conducting vaccine clinical trials among adolescents is imperative to achieve herd immunity against the coronavirus, J&J said in a statement

Conducting vaccine clinical trials among adolescents is imperative to achieve herd immunity against the coronavirus, J&J said in a statement File picture

Johnson & Johnson (JNJ.N) has sought approval from Indian drug regulators to conduct a study of its COVID-19 vaccine among 12- to 17-year-olds, the company said on Friday.

Conducting vaccine clinical trials among adolescents is imperative to achieve herd immunity against the coronavirus, J&J said in an emailed statement.

ADVERTISEMENT

The U.S. pharma giant had received emergency use approval for its single-dose vaccine in India earlier this month, making it the fifth authorised vaccine in the country.

While J&J has a supply agreement with Indian vaccine maker Biological E Ltd to bring its shot to the country, the company had said that it was too early to give a delivery timeline.

Follow us on:
ADVERTISEMENT
ADVERTISEMENT